What does Syndax Pharmaceuticals Inc (SNDX) do?

Syndax Pharmaceuticals Inc (SNDX) is a publicly traded company in the Healthcare sector.

What sector does SNDX operate in?

Syndax Pharmaceuticals Inc operates in the Healthcare, specifically within the Pharmaceutical Preparations industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find SNDX earnings analysis?

AlphaOS publishes an earnings intelligence page for Syndax Pharmaceuticals Inc (SNDX) covering results, guidance context, and AI-assisted analysis. See /stocks/SNDX/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

SNDX

Syndax Pharmaceuticals Inc

Healthcare · Pharmaceutical Preparations

$18.24Sep 29, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Syndax Pharmaceuticals Inc shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +92% YoY in Q2 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue +92% YoY in Q2 FY2026

Pipeline evidence · 22d ago

SNDX's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on SNDX.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full SNDX earnings analysis

Reported figures for Syndax Pharmaceuticals Inc — research only, not investment advice.

Revenue YoY: +91.8%

Latest Intelligence

Updated September 29, 2026

What happened recently for Syndax Pharmaceuticals Inc (SNDX) — events, not interpretation.

Event: Reported Q2 2026 revenue +92% YoY.
Also: Last session September 29, 2026 at $18.24.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Syndax Pharmaceuticals Inc (SNDX)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for Syndax Pharmaceuticals Inc — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Pharmaceutical Preparations
Market cap:: $1.63B
Revenue:: $72.79M

SNDX earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Syndax Pharmaceuticals Inc through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.